Nifty

:

11513.90

Sensex

:

39052.06

49.90 (0.44%)
453.07 (1.17%)

Login

Nifty
Sensex

:
:

11513.90
39052.06

49.90 (0.44%)
453.07 (1.17%)

Vivimed Labs Ltd.

Pharmaceuticals & Drugs

Rating :

28/99

BSE: 532660 | NSE: VIVIMEDLAB

Watchlist

NSE BSE

13.25

17-Oct-2019

Open
High
Low
Previous Close

13.45
13.50
13.00
13.25

Volume
Traded Value (lacs)
52 Week High
52 Week Low

57363
7.61
43.80
12.60

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

109.86
2.80
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

969.27
N/A
0.19

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

14.37
-0.96
-3.46

EBITDA CAGR (%)

10 Years
5 Years
3 Years

10.13
-5.31
-16.02

PAT CAGR (%)

10 Years
5 Years
3 Years

6.35
-4.45
-35.52

P:E (Median)

8 Years
5 Years
3 Years

5.90
6.07
4.04

P:BV (Average)

8 Years
5 Years
3 Years

1.03
0.94
0.79

EV:EBITDA (Average)

8 Years
5 Years
3 Years

5.70
5.61
5.07

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 19 Jun 18 Var% Mar 19 Mar 18 Var% Dec 18 Dec 17 Var% Sep 18 Sep 17 Var%
Net Sales 59.11 61.98 -4.63% 74.60 67.99 9.72% 51.72 65.89 -21.51% 63.50 61.15 3.84%
Expenses 46.48 44.74 3.89% 57.31 49.33 16.18% 35.97 46.31 -22.33% 46.53 41.12 13.16%
EBITDA 12.63 17.25 -26.78% 17.29 18.66 -7.34% 15.75 19.58 -19.56% 16.97 20.03 -15.28%
EBIDTM 21.37% 27.82% 23.17% 27.44% 30.45% 29.72% 26.73% 32.76%
Other Income 2.63 0.56 369.64% 7.64 1.45 426.90% 0.17 0.12 41.67% 0.16 0.00 0.00
Interest 9.97 11.39 -12.47% 18.14 13.86 30.88% 11.31 12.82 -11.78% 11.57 12.98 -10.86%
Depreciation 4.29 4.83 -11.18% 4.70 4.00 17.50% 4.31 4.74 -9.07% 4.42 4.94 -10.53%
PBT 1.00 1.60 -37.50% 2.09 2.26 -7.52% 0.30 2.15 -86.05% 1.15 2.12 -45.75%
Tax 0.25 0.32 -21.88% -0.42 -2.28 - -0.77 0.43 - -0.09 0.43 -
PAT 0.75 1.28 -41.41% 2.51 4.53 -44.59% 1.06 1.72 -38.37% 1.24 1.69 -26.63%
PATM 1.27% 2.06% 3.37% 6.67% 2.06% 2.61% 1.95% 2.77%
EPS 0.09 0.15 -40.00% 0.30 0.55 -45.45% 0.13 0.21 -38.10% 0.15 0.21 -28.57%

Description Jun 19 Jun 18 Var% Mar 19 Mar 18 Var% Dec 18 Dec 17 Var% Sep 18 Sep 17 Var%
Net Sales 344.21 358.54 -4.00% 348.08 285.61 21.87% 243.93 299.58 -18.58% 364.62 282.50 29.07%
Expenses 303.11 289.74 4.61% 326.69 251.87 29.71% 207.18 250.68 -17.35% 314.42 219.90 42.98%
EBITDA 41.10 68.80 -40.26% 21.39 33.74 -36.60% 36.74 48.89 -24.85% 50.20 62.60 -19.81%
EBIDTM 11.94% 19.19% 6.14% 11.82% 15.06% 16.32% 13.77% 22.16%
Other Income 1.27 5.75 -77.91% 6.10 2.87 112.54% 6.31 3.12 102.24% 5.04 0.61 726.23%
Interest 12.11 19.28 -37.19% 12.83 16.37 -21.62% 17.56 17.18 2.21% 17.59 21.36 -17.65%
Depreciation 16.95 15.87 6.81% 16.05 13.84 15.97% 15.29 13.94 9.68% 19.58 16.09 21.69%
PBT 13.31 39.40 -66.22% -1.40 6.41 - 10.21 20.89 -51.12% 18.07 25.78 -29.91%
Tax 3.16 10.95 -71.14% -1.41 -2.50 - -0.63 -0.03 - -0.21 3.71 -
PAT 10.15 28.46 -64.34% 0.01 8.91 -99.89% 10.84 20.92 -48.18% 18.28 22.07 -17.17%
PATM 2.95% 7.94% 0.00% 3.12% 4.44% 6.98% 5.01% 7.81%
EPS 1.22 3.45 -64.64% 0.00 1.30 -100.00% 1.31 2.53 -48.22% 2.21 2.69 -17.84%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales 248.93 251.81 261.39 569.84 319.39 430.15 431.99 423.13 382.90 309.81 210.59 Net Sales Growth -3.14% -3.67% -54.13% 78.42% -25.75% -0.43% 2.09% 10.51% 23.59% 47.12% Cost Of Goods Sold 89.77 80.30 86.40 179.93 131.55 197.90 234.65 239.81 227.73 194.39 126.00 Gross Profit 159.16 171.51 174.99 389.91 187.85 232.24 197.35 183.31 155.17 115.42 84.58 GP Margin 63.94% 68.11% 66.95% 68.42% 58.82% 53.99% 45.68% 43.32% 40.52% 37.26% 40.16% Total Expenditure 186.29 184.32 183.05 319.35 232.56 320.10 337.82 331.28 301.65 253.03 170.68 Power & Fuel Cost - 8.92 10.83 15.13 11.03 15.81 20.36 19.82 14.78 10.50 7.72 % Of Sales - 3.54% 4.14% 2.66% 3.45% 3.68% 4.71% 4.68% 3.86% 3.39% 3.67% Employee Cost - 37.88 34.09 42.23 23.99 27.88 19.83 15.51 10.58 10.54 10.20 % Of Sales - 15.04% 13.04% 7.41% 7.51% 6.48% 4.59% 3.67% 2.76% 3.40% 4.84% Manufacturing Exp. - 22.13 21.49 30.76 26.81 35.44 35.36 36.28 33.26 23.70 13.69 % Of Sales - 8.79% 8.22% 5.40% 8.39% 8.24% 8.19% 8.57% 8.69% 7.65% 6.50% General & Admin Exp. - 30.80 19.75 39.85 35.91 32.50 24.37 18.28 9.87 8.10 6.76 % Of Sales - 12.23% 7.56% 6.99% 11.24% 7.56% 5.64% 4.32% 2.58% 2.61% 3.21% Selling & Distn. Exp. - 4.28 5.28 3.21 3.27 3.61 3.25 1.57 5.42 4.37 3.57 % Of Sales - 1.70% 2.02% 0.56% 1.02% 0.84% 0.75% 0.37% 1.42% 1.41% 1.70% Miscellaneous Exp. - 0.01 5.21 8.23 0.00 6.94 0.00 0.00 0.00 1.42 3.57 % Of Sales - 0.00% 1.99% 1.44% 0% 1.61% 0% 0% 0% 0.46% 1.30% EBITDA 62.64 67.49 78.34 250.49 86.83 110.05 94.17 91.85 81.25 56.78 39.91 EBITDA Margin 25.16% 26.80% 29.97% 43.96% 27.19% 25.58% 21.80% 21.71% 21.22% 18.33% 18.95% Other Income 10.60 8.54 1.93 8.75 2.79 1.43 11.44 8.38 4.72 0.68 2.01 Interest 50.99 52.63 53.27 59.02 59.49 66.67 48.75 31.64 24.08 18.41 15.39 Depreciation 17.72 18.26 18.14 26.83 18.79 20.56 18.06 17.21 10.55 6.08 4.40 PBT 4.54 5.13 8.85 173.39 11.34 24.25 38.81 51.38 51.34 32.97 22.12 Tax -1.03 -1.05 -1.01 47.04 3.21 5.32 12.18 14.65 10.93 5.21 5.58 Tax Rate -22.69% -20.47% -11.41% 27.13% 28.31% 21.94% 31.38% 28.51% 21.29% 15.80% 25.23% PAT 5.56 6.19 9.87 126.34 8.13 18.93 26.63 36.73 40.41 27.76 16.54 PAT before Minority Interest 5.56 6.19 9.87 126.34 8.13 18.93 26.63 36.73 40.41 27.76 16.54 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 2.23% 2.46% 3.78% 22.17% 2.55% 4.40% 6.16% 8.68% 10.55% 8.96% 7.85% PAT Growth -39.70% -37.28% -92.19% 1,454.00% -57.05% -28.91% -27.50% -9.11% 45.57% 67.84% Unadjusted EPS 0.67 0.75 1.20 15.59 5.02 11.69 16.43 22.87 29.00 27.31 17.00

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales 1,300.84 1,315.17 1,185.66 1,461.91 1,345.63 1,380.10 1,350.83 1,108.80 668.31 416.00 343.49 Net Sales Growth 6.08% 10.92% -18.90% 8.64% -2.50% 2.17% 21.83% 65.91% 60.65% 21.11% Cost Of Goods Sold 533.96 518.40 479.67 536.28 624.05 646.23 656.33 513.27 337.39 236.97 203.49 Gross Profit 766.88 796.77 705.99 925.63 721.58 733.88 694.51 595.52 330.93 179.03 140.00 GP Margin 58.95% 60.58% 59.54% 63.32% 53.62% 53.18% 51.41% 53.71% 49.52% 43.04% 40.76% Total Expenditure 1,151.40 1,146.24 970.79 1,057.46 1,122.68 1,158.21 1,166.29 928.00 538.02 329.44 279.13 Power & Fuel Cost - 42.77 34.73 34.78 38.26 46.70 51.39 44.06 22.33 11.08 8.28 % Of Sales - 3.25% 2.93% 2.38% 2.84% 3.38% 3.80% 3.97% 3.34% 2.66% 2.41% Employee Cost - 241.76 197.78 189.98 176.94 184.43 162.66 50.33 32.19 19.97 22.07 % Of Sales - 18.38% 16.68% 13.00% 13.15% 13.36% 12.04% 4.54% 4.82% 4.80% 6.43% Manufacturing Exp. - 217.39 176.69 175.06 167.31 179.26 182.37 230.50 91.61 32.06 19.82 % Of Sales - 16.53% 14.90% 11.97% 12.43% 12.99% 13.50% 20.79% 13.71% 7.71% 5.77% General & Admin Exp. - 111.52 78.75 93.93 95.26 76.30 86.64 69.34 31.42 15.96 15.29 % Of Sales - 8.48% 6.64% 6.43% 7.08% 5.53% 6.41% 6.25% 4.70% 3.84% 4.45% Selling & Distn. Exp. - 14.41 16.66 15.39 20.86 25.29 26.91 20.50 23.09 11.26 9.32 % Of Sales - 1.10% 1.41% 1.05% 1.55% 1.83% 1.99% 1.85% 3.45% 2.71% 2.71% Miscellaneous Exp. - 0.00 -13.49 12.03 0.00 0.00 0.00 0.00 0.00 2.14 9.32 % Of Sales - 0% -1.14% 0.82% 0% 0% 0% 0% 0% 0.51% 0.25% EBITDA 149.43 168.93 214.87 404.45 222.95 221.89 184.54 180.80 130.29 86.56 64.36 EBITDA Margin 11.49% 12.84% 18.12% 27.67% 16.57% 16.08% 13.66% 16.31% 19.50% 20.81% 18.74% Other Income 18.72 33.97 9.61 8.09 23.63 8.02 35.90 26.33 2.68 1.00 6.84 Interest 60.09 70.06 82.35 67.79 85.26 86.20 67.46 50.44 28.37 22.10 22.82 Depreciation 67.87 66.79 56.42 58.28 61.39 66.18 66.12 58.81 26.79 10.20 8.73 PBT 40.19 66.05 85.71 286.48 99.93 77.54 86.86 97.88 77.82 55.26 39.65 Tax 0.91 8.68 9.62 72.50 16.26 5.49 20.47 14.29 14.68 6.43 8.63 Tax Rate 2.26% 13.14% 11.22% 25.31% 16.27% 7.08% 23.57% 14.60% 18.86% 11.64% 21.77% PAT 39.28 57.37 77.94 213.97 83.67 72.05 66.39 83.58 63.14 48.83 31.01 PAT before Minority Interest 39.28 57.37 76.09 213.97 83.67 72.05 66.39 83.58 63.14 48.83 31.01 Minority Interest 0.00 0.00 1.85 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 3.02% 4.36% 6.57% 14.64% 6.22% 5.22% 4.91% 7.54% 9.45% 11.74% 9.03% PAT Growth -51.12% -26.39% -63.57% 155.73% 16.13% 8.53% -20.57% 32.37% 29.31% 57.47% Unadjusted EPS 4.74 6.95 9.22 26.41 51.64 44.47 40.97 52.04 45.31 48.04 31.12

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 572.62 567.41 560.86 369.64 373.95 374.80 346.45 345.32 153.91 123.43 Share Capital 16.50 16.50 16.20 16.20 16.20 16.20 16.06 80.93 10.16 9.96 Total Reserves 556.12 550.90 544.66 353.44 357.75 356.22 328.01 262.01 134.89 108.51 Non-Current Liabilities 243.41 288.29 296.51 549.99 465.19 422.52 281.24 162.89 101.99 165.06 Secured Loans 34.39 66.66 131.24 143.28 260.86 250.36 142.21 75.71 74.74 147.18 Unsecured Loans 55.32 49.30 57.07 49.75 46.94 40.92 41.73 53.35 0.00 0.74 Long Term Provisions 9.54 7.17 2.74 3.38 3.01 2.35 1.97 1.81 1.65 0.00 Current Liabilities 338.52 399.72 503.14 445.75 463.61 406.10 327.11 269.28 172.60 30.61 Trade Payables 35.28 23.39 45.32 24.45 45.61 39.26 46.83 27.72 6.93 21.90 Other Current Liabilities 54.01 76.77 92.03 114.08 101.66 75.08 42.67 27.16 2.93 0.04 Short Term Borrowings 214.13 258.70 305.71 291.91 291.19 276.34 225.63 202.55 152.52 0.00 Short Term Provisions 35.10 40.86 60.07 15.31 25.15 15.42 11.97 11.84 10.22 8.68 Total Liabilities 1,154.55 1,255.42 1,360.51 1,365.38 1,302.75 1,203.42 954.80 777.49 428.50 319.10 Net Block 380.70 404.83 432.93 386.94 376.55 397.33 405.08 294.50 160.02 139.08 Gross Block 474.78 480.65 503.31 495.61 466.20 464.92 454.66 327.48 185.53 159.55 Accumulated Depreciation 94.08 75.82 70.39 108.67 89.65 67.59 49.58 32.98 25.50 20.47 Non Current Assets 532.41 599.47 579.17 657.81 669.87 640.39 509.84 389.37 164.56 142.91 Capital Work in Progress 64.18 42.78 58.64 40.83 63.27 15.51 9.21 7.71 1.14 0.34 Non Current Investment 87.53 151.87 87.60 230.05 230.05 227.55 95.55 87.17 3.40 3.49 Long Term Loans & Adv. 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 622.14 655.94 781.34 707.57 632.89 563.03 444.90 358.05 257.26 170.40 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 282.45 292.54 285.66 268.17 222.50 170.13 140.36 73.88 66.70 60.61 Sundry Debtors 101.89 167.67 224.85 230.86 228.07 183.79 160.06 98.72 95.96 75.32 Cash & Bank 24.96 9.18 15.55 7.18 13.99 13.26 13.67 19.41 8.63 3.41 Other Current Assets 212.86 20.28 16.92 25.63 168.32 195.84 130.81 166.05 85.97 31.07 Short Term Loans & Adv. 192.30 166.27 238.34 175.74 162.39 189.91 124.88 165.82 85.39 31.05 Net Current Assets 283.62 256.22 278.20 261.82 169.27 156.93 117.79 88.77 84.66 139.79 Total Assets 1,154.55 1,255.41 1,360.51 1,365.38 1,302.76 1,203.42 954.80 777.48 428.51 319.10

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 943.79 1,226.40 734.21 585.15 559.24 560.36 509.14 474.79 196.71 144.86 Share Capital 341.73 341.73 16.20 80.15 80.15 80.15 80.01 144.88 10.16 9.96 Total Reserves 602.07 884.67 718.01 505.00 479.09 477.84 426.77 327.54 177.68 129.94 Non-Current Liabilities 489.65 356.86 503.86 561.11 538.36 532.58 449.68 360.72 148.25 251.48 Secured Loans 369.08 275.90 396.25 206.75 436.44 378.81 255.19 258.03 131.90 234.55 Unsecured Loans 55.72 49.30 57.07 50.52 46.94 40.92 41.73 53.35 0.00 0.74 Long Term Provisions 9.21 7.03 2.19 3.57 3.17 5.16 1.47 1.06 1.69 0.00 Current Liabilities 888.93 790.23 817.39 897.41 800.86 744.42 610.73 463.69 242.44 59.38 Trade Payables 294.42 201.99 178.59 166.74 188.71 190.49 166.28 156.86 44.06 42.35 Other Current Liabilities 227.11 147.64 179.92 285.85 176.38 138.78 116.10 40.79 4.68 0.04 Short Term Borrowings 332.30 385.16 381.47 407.76 389.38 375.43 301.13 232.82 175.08 0.00 Short Term Provisions 35.10 55.43 77.41 37.06 46.39 39.71 27.22 33.21 18.61 17.00 Total Liabilities 2,322.37 2,385.77 2,055.46 2,043.67 1,898.46 1,837.36 1,569.55 1,299.20 587.40 455.72 Net Block 964.92 1,035.36 878.90 814.17 813.47 807.92 709.04 595.35 264.29 254.72 Gross Block 1,156.58 1,128.64 915.77 1,663.33 1,599.11 1,526.04 1,329.52 1,167.48 812.71 289.11 Accumulated Depreciation 191.65 93.29 36.87 849.16 785.64 718.12 620.49 572.13 548.42 34.39 Non Current Assets 1,091.77 1,103.83 961.04 911.03 906.45 846.28 736.20 604.41 266.01 255.86 Capital Work in Progress 122.31 65.27 76.13 94.17 90.28 38.12 26.92 8.37 1.73 1.14 Non Current Investment 2.51 2.70 2.71 2.69 2.70 0.24 0.24 0.70 0.00 0.00 Long Term Loans & Adv. 1.52 0.00 2.81 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Non Current Assets 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,230.61 1,281.94 1,094.42 1,132.60 991.96 970.90 815.08 647.14 314.68 194.06 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 563.69 540.17 483.97 490.80 431.43 426.66 340.26 247.88 84.47 79.35 Sundry Debtors 356.11 275.43 200.14 326.24 329.58 347.83 308.23 221.61 127.56 93.86 Cash & Bank 95.30 99.03 55.47 30.96 26.67 34.57 23.96 36.34 11.10 5.62 Other Current Assets 215.51 29.59 22.53 11.73 204.28 161.84 142.64 141.32 91.55 15.23 Short Term Loans & Adv. 184.76 337.73 332.31 272.88 185.21 139.50 119.82 141.09 89.45 15.20 Net Current Assets 341.68 491.71 277.03 235.19 191.10 226.47 204.35 183.45 72.25 134.67 Total Assets 2,322.38 2,385.77 2,055.46 2,043.67 1,898.45 1,837.36 1,569.55 1,299.21 587.39 455.73

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity 82.04 206.55 28.17 -54.21 41.29 -44.86 44.22 105.78 10.58 3.09 PBT 5.13 8.85 173.39 11.34 24.25 38.81 51.38 51.34 32.97 22.12 Adjustment 62.82 69.62 80.21 37.74 50.36 38.63 26.02 33.09 23.71 19.69 Changes in Working Capital 40.35 144.61 -213.96 -103.30 -33.33 -126.70 -39.12 20.70 -28.47 -24.29 Cash after chg. in Working capital 108.30 223.09 39.64 -54.21 41.29 -49.27 38.29 105.13 28.21 17.52 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -17.63 -14.44 Tax Paid -26.26 -16.54 -11.47 0.00 0.00 4.41 5.93 0.65 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 56.17 -38.12 29.83 -11.15 -50.04 -148.56 -107.67 -276.74 -81.50 8.87 Net Fixed Assets -15.53 38.52 -25.51 -6.97 -49.04 -16.56 -128.68 -148.52 -26.78 7.77 Net Investments 64.34 -64.27 142.45 0.00 -2.50 -132.00 -8.38 -83.77 0.09 -0.98 Others 7.36 -12.37 -87.11 -4.18 1.50 0.00 29.39 -44.45 -54.81 2.08 Cash from Financing Activity -123.23 -174.80 -49.62 58.54 9.48 193.01 57.71 181.73 76.15 -15.45 Net Cash Inflow / Outflow 14.98 -6.38 8.38 -6.82 0.74 -0.41 -5.74 10.77 5.23 -3.48 Opening Cash & Equivalents 9.18 15.55 7.18 13.99 13.26 13.67 19.41 8.63 3.41 6.89 Closing Cash & Equivalent 24.16 9.18 15.56 7.18 13.99 13.26 13.67 19.41 8.63 3.41

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity 422.14 21.42 57.96 154.12 140.48 -117.65 90.11 45.17 23.89 55.13 PBT 66.05 85.71 286.48 99.93 77.54 86.86 97.88 77.81 55.26 39.65 Adjustment 134.05 135.90 124.15 101.94 111.32 101.31 80.43 55.16 32.30 30.82 Changes in Working Capital 237.03 -158.14 -315.94 -47.75 -48.38 -305.83 -94.13 -87.81 -63.67 5.89 Cash after chg. in Working capital 437.13 63.48 94.69 154.12 140.48 -117.65 84.18 45.17 23.89 76.36 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -14.99 -42.06 -36.73 0.00 0.00 0.00 5.93 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -88.87 -163.53 -68.49 -190.42 -106.71 -291.11 -169.59 -424.15 -72.39 -7.13 Net Fixed Assets -15.53 38.52 -25.51 -6.97 -49.04 -16.56 -128.68 -148.52 -26.78 7.77 Net Investments 64.34 -64.27 142.45 0.00 -2.50 -132.00 -8.38 -83.77 0.09 -0.98 Others -137.68 -137.78 -185.43 -183.45 -55.17 -142.55 -32.53 -191.86 -45.70 -13.92 Cash from Financing Activity -337.80 185.66 35.05 40.59 -41.67 419.37 67.10 404.22 53.98 -59.36 Net Cash Inflow / Outflow -4.53 43.56 24.51 4.29 -7.90 10.62 -12.38 25.24 5.47 -11.35 Opening Cash & Equivalents 99.03 55.47 30.96 26.67 34.57 23.96 36.34 11.10 5.62 16.98 Closing Cash & Equivalent 94.50 99.03 55.47 30.96 26.67 34.57 23.96 36.34 11.10 5.62

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 64.78 64.15 64.53 45.50 46.03 45.84 42.71 35.15 27.03 22.41 ROA 0.51% 0.75% 9.27% 0.61% 1.51% 2.47% 4.24% 6.70% 7.43% 5.29% ROE 1.16% 1.88% 28.34% 2.19% 5.09% 7.45% 12.50% 21.15% 22.30% 16.95% ROCE 6.22% 6.01% 22.55% 6.95% 8.74% 9.74% 11.41% 14.51% 16.10% 14.34% Fixed Asset Turnover 0.53 0.53 1.14 0.66 0.92 0.94 1.08 1.49 1.80 1.39 Receivable days 195.36 274.06 145.95 262.23 174.74 145.26 111.61 92.79 100.90 112.53 Inventory Days 416.73 403.70 177.37 280.37 166.58 131.17 92.40 67.01 75.00 95.75 Payable days 43.93 69.44 41.99 56.35 44.37 46.49 40.12 20.32 20.58 43.06 Cash Conversion Cycle 568.16 608.32 281.33 486.25 296.96 229.95 163.90 139.47 155.32 165.23 Total Debt/Equity 0.65 0.84 1.09 1.62 1.87 1.71 1.29 1.13 1.65 1.32 Interest Cover 1.10 1.17 3.94 1.19 1.36 1.80 2.62 3.13 2.79 2.44

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 70.35 104.60 85.93 64.20 61.00 58.36 52.74 42.03 35.45 26.71 ROA 2.44% 3.43% 10.44% 4.25% 3.86% 3.90% 5.83% 6.69% 9.36% 6.87% ROE 7.95% 9.76% 35.18% 16.50% 14.90% 14.81% 23.34% 26.70% 31.18% 27.74% ROCE 7.03% 9.04% 21.86% 11.93% 10.91% 11.93% 13.83% 14.29% 17.80% 16.30% Fixed Asset Turnover 1.15 1.16 1.13 0.82 0.88 0.95 0.89 0.67 0.76 1.26 Receivable days 87.64 73.20 65.71 88.94 89.58 88.63 87.21 95.35 97.13 87.46 Inventory Days 153.18 157.64 121.69 125.08 113.47 103.61 96.80 90.76 71.87 78.89 Payable days 79.66 70.90 60.76 60.42 57.00 57.11 62.91 65.22 47.96 41.69 Cash Conversion Cycle 161.15 159.93 126.64 153.61 146.05 135.14 121.10 120.89 121.04 124.66 Total Debt/Equity 1.05 0.69 1.45 1.63 1.81 1.66 1.36 1.33 1.70 1.77 Interest Cover 1.94 2.04 5.23 2.17 1.90 2.29 2.94 3.74 3.50 2.74

Top Investors:

kitara piin 1102

sameer mahendra sampat

tushar rameshchandra mehta

kitara piin 1101

Annual Reports:

News Update:

Vivimed Labs enters into agreements for sale of its arm
7th Sep 2019, 16:04 PM

The company has entered into definitive agreement for sale its arm to Vivimed Specialty Chemicals UK
Read More
Vivimed Labs - Quarterly Results
9th Aug 2019, 22:44 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback